Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia

NCT00257660 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00257660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00257660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
October 10, 2005
Completion date
September 30, 2006
Enrollment
116 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia